Coherus Oncology Inc (CHRS) Cash Conversion Ratio & History | Stock Alarm

Demo Sign up Log In

Coherus Oncology Inc · Cash Conversion Ratio

CHRS Cash Conversion Ratio

Current (TTM)1.86×retrievedOct 20, 2026

CHRS Cash Conversion Ratio (0.61× → 1.86×)

Latest values, visible window

High-resolution chart · PNG

CHRS cash conversion ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Cash Conversion Ratio — Annual fiscal periods
Period ending	Cash Conversion Ratio
Dec 31, 2025	0.8134×
Dec 31, 2024	-0.717×
Dec 31, 2023	0.7363×
Dec 31, 2022	0.8335×
Dec 31, 2021	0.1349×
Dec 31, 2020	1.1109×
Dec 31, 2019	0.1721×
Dec 31, 2018	0.7646×
Dec 31, 2017	0.8601×
Dec 31, 2016	2.0344×
Dec 31, 2015	0.5113×
Dec 31, 2014	0.3073×
Dec 31, 2013	-0.2806×
Dec 31, 2012	0.6068×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.